$TRVN
TREVENA INC

2023 Q1 Form 10-K Financial Statement

#000155837023004988 Filed on March 30, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $6.000K $0.00 -$418.0K
YoY Change -70.0% -100.0% -173.72%
Cost Of Revenue $127.0K $227.0K $3.018M
YoY Change -38.65% -32.04% 216.35%
Gross Profit -$121.0K -$227.0K -$3.436M
YoY Change -35.29% -32.24% 787.86%
Gross Profit Margin -2016.67%
Selling, General & Admin $6.089M $5.725M $34.73M
YoY Change -44.72% -41.35% -8.88%
% of Gross Profit
Research & Development $3.909M $3.395M $18.21M
YoY Change -25.67% -13.77% 35.64%
% of Gross Profit
Depreciation & Amortization $82.00K $82.00K $400.0K
YoY Change -21.9% -22.64% 0.0%
% of Gross Profit
Operating Expenses $3.909M $9.120M $18.21M
YoY Change -25.67% -33.42% 35.64%
Operating Profit -$10.12M -$9.347M -$56.38M
YoY Change -38.52% -33.39% 8.57%
Interest Expense $446.0K -$332.0K $1.256M
YoY Change 1615.38% -1048.57% 125500.0%
% of Operating Profit
Other Income/Expense, Net $2.300M $2.674M $2.705M
YoY Change 3139.44% 5842.22% 702.67%
Pretax Income -$7.819M -$7.005M -$53.67M
YoY Change -52.29% -49.8% 4.04%
Income Tax
% Of Pretax Income
Net Earnings -$7.819M -$7.005M -$53.67M
YoY Change -52.29% -49.8% 4.04%
Net Earnings / Revenue -130316.67%
Basic Earnings Per Share -$0.81 -$7.59
Diluted Earnings Per Share -$0.81 -$0.85 -$7.59
COMMON SHARES
Basic Shares Outstanding 8.975M 173.7M 7.072M
Diluted Shares Outstanding 9.594M 7.072M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $27.44M $38.32M $38.32M
YoY Change -43.62% -42.74% -42.74%
Cash & Equivalents $27.44M $38.32M $38.32M
Short-Term Investments
Other Short-Term Assets $2.425M $1.782M $1.782M
YoY Change -14.61% 23.07% 23.07%
Inventory $906.0K $906.0K $906.0K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $30.77M $41.01M $41.01M
YoY Change -43.29% -42.02% -42.02%
LONG-TERM ASSETS
Property, Plant & Equipment $1.406M $1.488M $5.712M
YoY Change -19.01% -19.17% -12.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $59.00K $1.960M $1.960M
YoY Change -97.67% 27.03% -31.32%
Total Long-Term Assets $7.525M $7.672M $7.672M
YoY Change -25.99% -18.39% -18.39%
TOTAL ASSETS
Total Short-Term Assets $30.77M $41.01M $41.01M
Total Long-Term Assets $7.525M $7.672M $7.672M
Total Assets $38.29M $48.68M $48.68M
YoY Change -40.56% -39.24% -39.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.664M $2.372M $2.372M
YoY Change -30.9% -47.83% -47.83%
Accrued Expenses $6.346M $6.351M $4.389M
YoY Change -2.61% 37.02% 16.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.000K $9.000K $9.000K
YoY Change 350.0% 125.0% 125.0%
Total Short-Term Liabilities $8.019M $8.732M $8.732M
YoY Change -10.16% -4.94% -4.94%
LONG-TERM LIABILITIES
Long-Term Debt $13.48M $13.43M $13.45M
YoY Change
Other Long-Term Liabilities $6.628M $10.90M $10.90M
YoY Change 8.73% 72.8% 72.8%
Total Long-Term Liabilities $13.48M $13.43M $24.35M
YoY Change 121.06% 112.87% 285.94%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.019M $8.732M $8.732M
Total Long-Term Liabilities $13.48M $13.43M $24.35M
Total Liabilities $28.14M $33.08M $33.08M
YoY Change 87.31% 113.49% 113.49%
SHAREHOLDERS EQUITY
Retained Earnings -$555.6M -$547.8M
YoY Change 8.83% 10.87%
Common Stock $565.7M $563.4M
YoY Change 1.05% 0.83%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $10.15M $15.60M $15.60M
YoY Change
Total Liabilities & Shareholders Equity $38.29M $48.68M $48.68M
YoY Change -40.56% -39.24% -39.24%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$7.819M -$7.005M -$53.67M
YoY Change -52.29% -49.8% 4.04%
Depreciation, Depletion And Amortization $82.00K $82.00K $400.0K
YoY Change -21.9% -22.64% 0.0%
Cash From Operating Activities -$10.87M -$10.66M -$51.48M
YoY Change -40.44% -15.47% 2.55%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $28.00K
YoY Change 75.0%
Acquisitions
YoY Change
Other Investing Activities $18.00M $46.00K
YoY Change 1446.39%
Cash From Investing Activities $18.00M $18.00K
YoY Change 1446.39% -212.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.000K 7.956M 23.51M
YoY Change 0.0% -3035.79% 203.92%
NET CHANGE
Cash From Operating Activities -10.87M -10.66M -51.48M
Cash From Investing Activities 18.00M 18.00K
Cash From Financing Activities -2.000K 7.956M 23.51M
Net Change In Cash -10.88M 15.29M -27.95M
YoY Change -40.43% -230.44% -34.19%
FREE CASH FLOW
Cash From Operating Activities -$10.87M -$10.66M -$51.48M
Capital Expenditures $0.00 $28.00K
Free Cash Flow -$10.66M -$51.51M
YoY Change -15.47% 2.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.59
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7072362
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6529074
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7072362
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6529074
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.59
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.90
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent
CY2022Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent
CY2021Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2021Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2022Q4 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2021Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent
CY2022Q4 us-gaap Finance Lease Liability Current Statement Of Financial Position Extensible List
FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent
CY2021Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2022Q4 us-gaap Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List
FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2021Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2022Q4 us-gaap Finance Lease Liability Statement Of Financial Position Extensible List
FinanceLeaseLiabilityStatementOfFinancialPositionExtensibleList
http://www.trevenainc.com/20221231#LeaseLiabilityCurrent http://www.trevenainc.com/20221231#LeaseLiabilityNoncurrent
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001429560
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
TREVENA INC
CY2021 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7744692
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6618093
CY2022Q4 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.04
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-36193
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-1469215
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
955 Chesterbrook Blvd.
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 110
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Chesterbrook
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19087
CY2022 dei City Area Code
CityAreaCode
610
CY2022 dei Local Phone Number
LocalPhoneNumber
354-8840
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
TRVN
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
276000000.0
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8975072
CY2022 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2022 dei Auditor Location
AuditorLocation
Philadelphia, Pennsylvania
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
38320000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66923000
CY2022Q4 us-gaap Inventory Net
InventoryNet
906000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2352000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1782000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1448000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
41008000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
70723000
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1960000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
1311000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1488000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1841000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4224000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4706000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1543000
CY2022Q4 us-gaap Assets
Assets
48680000
CY2021Q4 us-gaap Assets
Assets
80124000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2372000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4547000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5461000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3847000
CY2022Q4 trvn Lease Liability Current
LeaseLiabilityCurrent
899000
CY2021Q4 trvn Lease Liability Current
LeaseLiabilityCurrent
792000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8732000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
9186000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13430000
CY2022Q4 trvn Lease Liability Noncurrent
LeaseLiabilityNoncurrent
5436000
CY2021Q4 trvn Lease Liability Noncurrent
LeaseLiabilityNoncurrent
6309000
CY2022Q4 trvn Preferred Stock Warrant Liability Non Current
PreferredStockWarrantLiabilityNonCurrent
5483000
CY2022Q4 us-gaap Liabilities
Liabilities
33081000
CY2021Q4 us-gaap Liabilities
Liabilities
15495000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7744692
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6618093
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
8000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
563362000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
558724000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-547772000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494102000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15599000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64629000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
48680000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
80124000
CY2022 trvn Revenue From Contract With Customer Including Assessed Tax Net Of Returns Reserve
RevenueFromContractWithCustomerIncludingAssessedTaxNetOfReturnsReserve
-418000
CY2021 trvn Revenue From Contract With Customer Including Assessed Tax Net Of Returns Reserve
RevenueFromContractWithCustomerIncludingAssessedTaxNetOfReturnsReserve
567000
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
3018000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
954000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
34728000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
38112000
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18211000
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13426000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
55957000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
52492000
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-56375000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-51925000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11180000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-7681000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
172000
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
451000
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
162000
CY2022 us-gaap Interest Expense
InterestExpense
1256000
CY2021 us-gaap Interest Expense
InterestExpense
1000
CY2022 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
11000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
-2000
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2705000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
337000
CY2022 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-53670000
CY2021 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-51588000
CY2022 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1000
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53669000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51588000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.90
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7072362
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6529074
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
104068000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
4407000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
187000
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
7949000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-394000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-51588000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
64629000
CY2022 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
3676000
CY2022 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
603000
CY2022 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
-37000
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
397000
CY2022 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68234000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
110713000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
40280000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
68234000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
604000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-53670000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15599000
CY2022 us-gaap Profit Loss
ProfitLoss
-53670000
CY2021 us-gaap Profit Loss
ProfitLoss
-51588000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
382000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
428000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
3676000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
4407000
CY2022 us-gaap Paid In Kind Interest
PaidInKindInterest
128000
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
2070000
CY2022 trvn Fair Value Of Warrants In Excess Of Proceeds
FairValueOfWarrantsInExcessOfProceeds
7147000
CY2022 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-11180000
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6000
CY2022 trvn Returns Reserve Adjustment
ReturnsReserveAdjustment
383000
CY2022 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
46000
CY2022 trvn Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-482000
CY2021 trvn Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-413000
CY2022 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1209000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2337000
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
624000
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2352000
CY2021 us-gaap Increase Decrease In Insurance Settlements Receivable
IncreaseDecreaseInInsuranceSettlementsReceivable
-9000000
CY2021 trvn Increase Decrease In Litigation Reserve
IncreaseDecreaseInLitigationReserve
-9000000
CY2022 trvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-758000
CY2021 trvn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-695000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-676000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1533000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-51477000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50197000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000
CY2022 us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
33000000
CY2022 us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
32954000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
187000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7948000
CY2022 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
37000
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
393000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
CY2022 trvn Proceeds From Issuance Of Common Stock Warrants And Prefunded Warrants
ProceedsFromIssuanceOfCommonStockWarrantsAndPrefundedWarrants
7997000
CY2022 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
13906000
CY2022 trvn Proceeds From Issuance Of Long Term Debt And Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfLongTermDebtAndProceedsFromIssuanceOfWarrants
1647000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23505000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
7734000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-27954000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-42479000
CY2022 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
397000
CY2022 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-547800000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-53700000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-51600000
CY2022Q4 us-gaap Share Price
SharePrice
3.05
CY2022Q2 trvn Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
3
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Management used significant estimates in the following areas, among others: stock-based compensation expense, the determination of the fair value of stock-based awards, the fair value of common stock warrants, the accounting for research and development costs, accrued expenses, the recoverability of the Company’s net deferred tax assets and related valuation allowance, and the amortization of the debt expenses. The financial data and other information disclosed in these notes are not necessarily indicative of the results to be expected for any future year or period. The Company bases its estimates on historical experience and also on assumptions that it believes are reasonable, however, actual results could significantly differ from those results.</p>
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
136000
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk are primarily cash, cash equivalents, and restricted cash. The Company’s investment policy includes guidelines on the quality of the institutions and financial instruments and defines allowable investments that the Company believes minimizes the exposure to concentration of credit risk. The Company has no off-balance sheet concentrations of credit risk such as foreign currency exchange contracts, option contracts or other hedging arrangements.</p>
CY2022 trvn Number Of Stock Based Compensation Plans
NumberOfStockBasedCompensationPlans
2
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
9651000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
40280000
CY2021Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
8148000
CY2021Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
68234000
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3111000
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2488000
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
2205000
CY2022Q4 us-gaap Inventory Net
InventoryNet
906000
CY2021Q4 us-gaap Inventory Net
InventoryNet
2352000
CY2022 trvn Increase Decrease In Inventory Valuation Adjustment
IncreaseDecreaseInInventoryValuationAdjustment
2100000
CY2021 trvn Increase Decrease In Inventory Valuation Adjustment
IncreaseDecreaseInInventoryValuationAdjustment
100000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4250000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4334000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2762000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2493000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1488000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1841000
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
400000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1965000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2132000
CY2022Q4 trvn Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
93000
CY2021Q4 trvn Accrued Commercial Expenses Current
AccruedCommercialExpensesCurrent
107000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
381000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
124000
CY2022Q4 trvn Accrued Clinical Trial Fees Current
AccruedClinicalTrialFeesCurrent
1421000
CY2021Q4 trvn Accrued Clinical Trial Fees Current
AccruedClinicalTrialFeesCurrent
550000
CY2022Q4 trvn Accrued Development Expenses Current
AccruedDevelopmentExpensesCurrent
201000
CY2021Q4 trvn Accrued Development Expenses Current
AccruedDevelopmentExpensesCurrent
161000
CY2022Q4 trvn Accrued Credit Balances To Customers
AccruedCreditBalancesToCustomers
67000
CY2021Q4 trvn Accrued Credit Balances To Customers
AccruedCreditBalancesToCustomers
87000
CY2021Q4 trvn Accrued Purchases Current
AccruedPurchasesCurrent
271000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
522000
CY2022Q4 trvn Other Accrued Expenses And Other Current Liabilities
OtherAccruedExpensesAndOtherCurrentLiabilities
811000
CY2021Q4 trvn Other Accrued Expenses And Other Current Liabilities
OtherAccruedExpensesAndOtherCurrentLiabilities
415000
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
5461000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
3847000
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
15000000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
1570000
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
13430000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
13430000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2022Q3 trvn Proceeds From Issuance Of Convertible Preferred Stock Gross
ProceedsFromIssuanceOfConvertiblePreferredStockGross
2000000
CY2021Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
11014
CY2022 trvn Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Granted
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRightsGranted
4983760
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
4994774
CY2022 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3676000
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4407000
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.000
CY2022Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5734292
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4224000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4706000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
890000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
788000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5419000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6309000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6309000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
7097000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
9000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
4000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
26000
CY2021Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4000
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
1308000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
1228000
CY2022 us-gaap Sublease Income
SubleaseIncome
1330000
CY2021 us-gaap Sublease Income
SubleaseIncome
1186000
CY2022 trvn Operating Lease Income Expense Net
OperatingLeaseIncomeExpenseNet
-22000
CY2021 trvn Operating Lease Income Expense Net
OperatingLeaseIncomeExpenseNet
42000
CY2022 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7000
CY2021 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
7000
CY2022 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2021 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2022 trvn Finance Lease Cost
FinanceLeaseCost
8000
CY2021 trvn Finance Lease Cost
FinanceLeaseCost
8000
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
295000
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
265000
CY2022 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
8000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1425000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
11000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1450000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
11000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1474000
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
7000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1499000
CY2022Q4 trvn Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
2163000
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
8011000
CY2022Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
29000
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1702000
CY2022Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
3000
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6309000
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
26000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
1139000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
995000
CY2022Q4 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
2134000
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y
CY2022Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P3Y
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.092
CY2022Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.065
CY2021Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.065
CY2022Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
100000
CY2021Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
0
CY2021Q4 trvn Accounts Receivable Allowance For Credit Loss Sales Discounts
AccountsReceivableAllowanceForCreditLossSalesDiscounts
1000
CY2021Q4 trvn Accounts Receivable Allowance For Credit Loss Chargebacks
AccountsReceivableAllowanceForCreditLossChargebacks
41000
CY2021Q4 trvn Accounts Receivable Allowance For Credit Loss Fee For Service
AccountsReceivableAllowanceForCreditLossFeeForService
45000
CY2022 trvn Accounts Receivable Credit Loss Chargebacks Expense Reversal
AccountsReceivableCreditLossChargebacksExpenseReversal
-11000
CY2022 trvn Accounts Receivable Credit Loss Fee For Service Expense Reversal
AccountsReceivableCreditLossFeeForServiceExpenseReversal
-9000
CY2022Q4 trvn Accounts Receivable Allowance For Credit Loss Sales Discounts
AccountsReceivableAllowanceForCreditLossSalesDiscounts
1000
CY2022Q4 trvn Accounts Receivable Allowance For Credit Loss Chargebacks
AccountsReceivableAllowanceForCreditLossChargebacks
30000
CY2022Q4 trvn Accounts Receivable Allowance For Credit Loss Fee For Service
AccountsReceivableAllowanceForCreditLossFeeForService
36000
CY2022Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
19000
CY2022Q4 trvn Accounts Receivable Allowance For Credit Loss
AccountsReceivableAllowanceForCreditLoss
67000
CY2022 trvn Returns Reserve Adjustment
ReturnsReserveAdjustment
400000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-53670000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-51588000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7072362
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6529074
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.59
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.90
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
436000
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
381000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
436000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
381000
CY2022Q4 trvn Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
147345000
CY2021Q4 trvn Deferred Tax Assets Liabilities Net Before Valuation Allowance
DeferredTaxAssetsLiabilitiesNetBeforeValuationAllowance
154878000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
147345000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
154878000
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2021Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2022 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3858538
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
729371
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-7500000
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
14400000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
46490000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
40810000
CY2022Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
16309000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
15575000
CY2022Q4 trvn Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes
DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes
80648000
CY2021Q4 trvn Deferred Tax Assets Research And Development Expenses Capitalized For Tax Purposes
DeferredTaxAssetsResearchAndDevelopmentExpensesCapitalizedForTaxPurposes
93254000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
2257000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3960000
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
520000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Deferred Rent
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsDeferredRent
691000
CY2022Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
365000
CY2021Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
312000
CY2022Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1192000
CY2021Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
657000
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
147781000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
155259000
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.013
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.002
CY2022 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.048
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.072
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.015
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment
0.013
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
-0.377
CY2022 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.032
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.014
CY2022 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.017
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.140
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.280
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022 trvn Research And Development Expense Capitalized
ResearchAndDevelopmentExpenseCapitalized
18700000
CY2022 trvn Effective Income Tax Rate Reconciliation At State Statutory Income Tax Rate Percent
EffectiveIncomeTaxRateReconciliationAtStateStatutoryIncomeTaxRatePercent
0.0999
CY2022 trvn Deferred State And Local Income Tax Expense From Change In Tax Rates Benefit
DeferredStateAndLocalIncomeTaxExpenseFromChangeInTaxRatesBenefit
25700000
CY2022 trvn Defined Contribution Plan Employer Matching Contribution Percent Of Match For First Eligible Contributions
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForFirstEligibleContributions
1
CY2022 trvn Defined Contribution Plan Employer Match Employee Contribution Level One
DefinedContributionPlanEmployerMatchEmployeeContributionLevelOne
0.03
CY2022 trvn Defined Contribution Plan Employer Matching Contribution Percent Of Match For Second Eligible Contributions
DefinedContributionPlanEmployerMatchingContributionPercentOfMatchForSecondEligibleContributions
0.50
CY2022 trvn Defined Contribution Plan Employer Match Employee Contribution Level Two
DefinedContributionPlanEmployerMatchEmployeeContributionLevelTwo
0.02
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000
CY2022 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
300000
CY2022 dei Auditor Firm
AuditorFirmId
42

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
trvn-20221231x10k_htm.xml Edgar Link completed
0001558370-23-004988-index-headers.html Edgar Link pending
0001558370-23-004988-index.html Edgar Link pending
0001558370-23-004988.txt Edgar Link pending
0001558370-23-004988-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
trvn-20221231.xsd Edgar Link pending
trvn-20221231x10k.htm Edgar Link pending
trvn-20221231x10k003.jpg Edgar Link pending
trvn-20221231xex23d1.htm Edgar Link pending
trvn-20221231xex31d1.htm Edgar Link pending
trvn-20221231xex31d2.htm Edgar Link pending
trvn-20221231xex32d1.htm Edgar Link pending
trvn-20221231xex32d2.htm Edgar Link pending
trvn-20221231_cal.xml Edgar Link unprocessable
trvn-20221231_lab.xml Edgar Link unprocessable
trvn-20221231_def.xml Edgar Link unprocessable
trvn-20221231_pre.xml Edgar Link unprocessable